DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, operating a network of kidney dialysis centers and offering lab services in outpatient settings. The company delivers outpatient, hospital inpatient, and home-based hemodialysis services, and owns clinical laboratories that perform routine lab tests for dialysis and other physician-prescribed tests for ESRD patients. Additionally, DaVita Inc. offers management and administrative support to outpatient dialysis centers, disease management services to 16,000 patients in risk-based integrated care arrangements, and 7,000 patients in other integrated care arrangements. The company also provides vascular access services, clinical research programs, physician services, and comprehensive kidney care solutions. As of December 31, 2021, DaVita Inc. managed dialysis and administrative services across the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients. Furthermore, it operated 339 outpatient dialysis centers in 10 countries outside the United States, catering to about 39,900 patients. In addition, the company provided acute inpatient dialysis services in around 850 hospitals together with related lab services throughout the U.S. The operating income ratio is 0.15 indicating the company's operational profitability margin, while it reported depreciation and amortization expenses of $715,348,000.00 reflecting the wear and tear of its assets. The EBITDA ratio stands at 0.19 highlighting the company's operational efficiency, and the earnings per share (EPS) is reported at $9.72 showcasing profitability on a per-share basis. The company reported a substantial revenue of $13,643,069,000.00 reflecting its strong market presence. DaVita Inc.'s stock is reasonably priced at $130.16 appealing to a broad range of investors. With an average trading volume of 1,095,110.00 the stock indicates moderate liquidity, making it accessible for trading. The company enjoys a mid-range market capitalization of $10,323,491,070.00 signifying its role as a steady performer in the market. It is a key player in the Medical - Care Facilities industry, contributing significantly to the overall market landscape and driving innovation and growth within the Healthcare sector.